CLAIM #49468 · Palantir Technologies Inc. (PLTR) · 2023Q2 earnings call · Aug 7, 2023 · due Dec 31, 2023
“We expect this trend to continue.”
Ryan Taylor · Chief Revenue Officer and Chief Legal Officer
In context
“Tampa General has seen a 28% reduction in patient hold times and has reduced the time spent managing patient placements by 83%. And Cleveland Clinic has been able to accept an 8.5% increase in patient transfers from other hospitals in just four months since launch. While we continue to increase our breadth and expansion across industries, we also continue to grow at our existing customers. We had over two dozen U.S. commercial customers that brought in more than $1 million in revenue each during last quarter alone and we’re seeing outsized growth from our newest customers, 54% of the U.S. commercial revenue, excluding strategic commercial contracts is from customers that have started since the beginning of 2021 with nearly all of the year-over-year growth coming from those same customers. We expect this trend to continue. We are investing in pockets of momentum within our international commercial business, such as Japan, Korea, Canada and the Middle East, among other targeted opportunities across the world. For example, through our go-to-market partnership, Fujitsu has seen recent success onboarding eight new large-cap household name Japanese customers. At the same time, we are seeing AIP lead to expansion conversations with our largest longstanding customers in Europe, all against the challenging backdrop of today’s climate. On the international government side, our U.K. Government business was particularly strong in Q2 as a result of our work with organizations such as the NHS and U.K. Ministry of Defense, including the Royal Navy. Within our U.S. Government business, while the revenue results in Q2 are”
Verify independently
SEC filings for PLTR ↗ · Claim quote is verbatim from the 2023Q2 earnings call.